A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Lance Leopold, MD
Incyte Corporation
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Grand Hopital de Charleroi - Department of Medical Oncology
Brussels, Belgium
- Institut Jules Bordet - Clinical Trials Conduct Unit
Brussels, Belgium
- Ucl Cancer Institute
London, United Kingdom
- the Christie Nhs Foundation Trust
Manchester, United Kingdom
- University of Alabama
Birmingham, Alabama, United States
- Usa Mitchell Cancer Center
Mobile, Alabama, United States
- Uc Davis - Comprehensive Cancer Centre
Sacramento, California, United States
- Northwest Georgia Oncology Centers
Marietta, Georgia, United States
- the University of Texas Md Anderson Cancer Center
Houston, Texas, United States
- Start San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Nov 2017
- Primary completion
- 28 Nov 2022
- Completion
- 28 Nov 2022
- Last update posted
- 12 Aug 2025
- Registered enrollment
- 149
- Registry id
- NCT03314935
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.